ClearAlpha Technologies »

ImmunoGen shares owned by ClearAlpha Technologies

Quarter-by-quarter ownership of ImmunoGen shares owned by ClearAlpha Technologies from 13F filings

Historical chart of ClearAlpha Technologies investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by ClearAlpha Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by ClearAlpha Technologies

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 101k 29.65

More positions owned by ClearAlpha Technologies

Hess (HES)
Pioneer Natural Resources (PXD)
stock
Albertsons Cos Common Stock (ACI)
Capri Holdings SHS (CPRI)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Amedisys (AMED)
Sovos Brands
Rover Group Com Cl A
Fox Corp Cl A Com (FOXA)
ImmunoGen
MGIC Investment (MTG)
Goldman Sachs (GS)
Loews Corporation (L)
Taylor Morrison Hom (TMHC)

View all positions for ClearAlpha Technologies

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen